Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN)

CAPS Rating: 3 out of 5

A biotechnology company working to develop and deliver life-changing drug therapies for patients with serious and life-threatening medical conditions.

Recs

0
Player Avatar SnowBawl (< 20) Submitted: 10/26/2011 8:10:48 AM : Outperform Start Price: $66.77 ALXN Score: +31.22

Increasing sales and margins screen. (master list).

Featured Broker Partners


Advertisement